Brainstorm Cell Therapeutics's total assets for Q3 2025 were $872.00K, a decrease of -66.02% from the previous quarter. BCLI total liabilities were $50.00K for the fiscal quarter, a -99.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.